Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Saw palmetto claim

This article was originally published in The Tan Sheet

Executive Summary

Petition for rehearing en banc denied for supplement marketers seeking a health claim linking saw palmetto to benign prostatic hyperplasia. The petition was filed on behalf of the plaintiffs by Washington, D.C. law firm Emord & Associates Feb. 19 (1"The Tan Sheet" March 1, 2004, p. 15). Julian Whitaker, MD, the American Association for Health Freedom, Pure Encapsulations, Durk Pearson and Sandy Shaw plan to petition for a writ of certiorari to the Supreme Court before June 7...
Advertisement

Related Content

Saw Palmetto En Banc Appeals Court Re-Hearing Requested
Saw Palmetto En Banc Appeals Court Re-Hearing Requested

Topics

Advertisement
UsernamePublicRestriction

Register

PS096620

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel